Herbal Medicines Show Promise in Reducing Radiation Vaginitis in Cervical Cancer Patients: Study

A recent meta-analysis published in Frontiers in Pharmacology by Zhang and colleagues has shown that herbal medicines (HMs) may offer meaningful benefits in reducing radiation-induced vaginitis among cervical cancer patients undergoing radiotherapy.

The study found that patients receiving HMs experienced lower rates and milder symptoms of radiation vaginitis compared to those on conventional treatment alone. Additionally, herbal interventions appeared to enhance therapeutic effectiveness, lower recurrence rates, and shorten recovery time. The authors noted that these outcomes suggest HMs could serve as a valuable complementary approach in supportive care for women receiving pelvic radiotherapy.

According to the researchers, radiation vaginitis is a common and distressing side effect of pelvic irradiation, often leading to pain, discharge, and discomfort that can affect treatment adherence and quality of life. The analysis revealed that specific herbal formulations with anti-inflammatory, antioxidant, and mucosal-healing properties might protect vaginal tissue from radiation damage. Herbs such as *Sophora flavescens*, *Scutellaria baicalensis*, and *Astragalus membranaceus* were frequently included in the studies analyzed, demonstrating potential in modulating immune responses and promoting epithelial repair. These pharmacological actions may explain the observed symptom relief and improved local tissue recovery.